THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 116 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54 | -15.6% | 6,228 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $64 | -33.3% | 6,228 | -29.5% | 0.00% | 0.0% |
| Q1 2023 | $96 | -15.8% | 8,839 | -12.7% | 0.00% | 0.0% |
| Q4 2022 | $114 | -99.9% | 10,124 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $103,000 | +14.4% | 10,124 | +1.5% | 0.00% | 0.0% |
| Q2 2022 | $90,000 | -1.1% | 9,978 | +4.4% | 0.00% | 0.0% |
| Q1 2022 | $91,000 | -60.1% | 9,556 | -53.7% | 0.00% | 0.0% |
| Q4 2021 | $228,000 | +192.3% | 20,650 | +95.6% | 0.00% | 0.0% |
| Q3 2021 | $78,000 | -62.5% | 10,559 | +31.6% | 0.00% | -75.0% |
| Q4 2019 | $208,000 | -2.8% | 8,024 | +49.7% | 0.00% | -42.9% |
| Q2 2017 | $214,000 | – | 5,360 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Link Fund Solutions Ltd | 5,251,349 | $135,459,000 | 69.86% |
| Chescapmanager LLC | 949,006 | $24,570,000 | 3.61% |
| Baupost Group | 9,309,168 | $241,014,000 | 2.66% |
| Rock Springs Capital Management LP | 655,200 | $16,963,000 | 0.54% |
| Rubric Capital Management LP | 173,400 | $4,489,000 | 0.51% |
| Newtyn Management, LLC | 173,300 | $4,487,000 | 0.41% |
| NJ State Employees Deferred Compensation Plan | 38,142 | $988,000 | 0.17% |
| King Wealth Management Group | 22,500 | $583,000 | 0.15% |
| Virtus ETF Advisers LLC | 29,216 | $756,000 | 0.12% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 452,615 | $11,718,000 | 0.12% |